Cellply
Automated instrument and analysis software for characterizing immune cells in cell therapy R&D, sold to biopharma and research labs
Highlights
- Hiring1 open role
- New on EvolcAdded 2026-10-17
About Cellply
Cellply develops the VivaCyte platform, a standalone automated system for analyzing immune cells in cell therapy development. The system combines disposable microfluidic CC-Array plates, an instrument for sample preparation and cell analysis, control software for workflow configuration, and machine-learning image analysis at single-cell resolution.
According to its website, Cellply supports biopharma companies and research institutes from discovery through R&D to quality control of advanced therapies. Its products are sold directly, with a sales contact listed for the US market and a separate contact for EMEA and APAC. The company describes its technology as adopted by biopharma companies and research institutes worldwide.
The company's operating office is in Bologna, Italy. The website lists a leadership team and board of directors, and an open Field Service Engineer position in Bologna covering installation, maintenance and customer technical support for VivaCyte systems. The website does not state a founding year or funding details.
Product: VivaCyte platform: standalone automated cell therapy characterization instrument with disposable CC-Array microfluidic plates and analysis software
Open jobs (1)
Field Service Engineer
New on Evolc
Leadership
- Alessia Zanelli · PresidentSource: company website
- Alex Jones · Chief Executive OfficerSource: company website
- Andrea Faenza · Chief Technology OfficerSource: company website
- Massimo Bocchi · Co-Founder and Chief Operating OfficerSource: company website
- Priyanka Dutta Passecker · Chief Business OfficerSource: company website
Tech stack
- Google Tag Manager
- Google reCAPTCHA
- Next.js
- React
- Tailwind CSS
- Workable